US biopharma: "nearly 300 vaccines in R&D"

Article Date: 24/04/2012 06:00
US biopharma: "nearly 300 vaccines in R&D"

Vacancy Search

Quick job search

Advanced Search

Latest News

BI's Pradaxa available on the NHS for blood clots

BI's Pradaxa available on the NHS for blood clots

Philips buys Volcano and hopes it will not get burned

Is that it for 2014? Or will this remarkable year see another medtech megamerger before midnight on New Year’s Eve? That Philips spending $1.2bn on vascular imaging company Volcano is only...

Auspex drug on target in Ph III Huntington's trial

Auspex drug on target in Ph III Huntington's trial

Pfizer's Inlyta close to approval for NHS use

Pfizer's Inlyta close to approval for NHS use

Janssen launches HIV combo Rezolsta in UK

Janssen launches HIV combo Rezolsta in UK

EMA says much more info needed on Ebola meds

EMA says much more info needed on Ebola meds

FDA gives green light to Novartis acromegaly drug

FDA gives green light to Novartis acromegaly drug

NHS cost watchdog in favour of Bayer's Xofigo

NHS cost watchdog in favour of Bayer's Xofigo

Sophiris proves its doubters correct

Sometimes it pays to go with your gut instinct. A case in point is Sophiris Bio, which had struggled to raise $65m in a Nasdaq float last year, ultimately having to price at 62% below its...

US breakthrough status for Genentech's Lucentis

US breakthrough status for Genentech's Lucentis
more news